文献速递冠心病

MicroRNA-210 调控线粒体代谢并保护心肌梗死后的心脏功能

MicroRNA-210 Controls Mitochondrial Metabolism and Protects Heart Function in Myocardial Infarction.
PubMed 文献 · Circulation · 2022-03-17

该研究在小鼠心肌缺血再灌注(IR)模型中比较 microRNA-210 缺失与野生型的损失/获得功能实验,发现 microRNA-210 缺失加重雄性小鼠心功能障碍,静脉注射 microRNA-210 模拟物可逆转;机制上 microRNA-210 靶向线粒体甘油-3-磷酸脱氢酶调控线粒体生物能量学与 ROS 通量。

要点

  • microRNA-210 缺失加重雄性而非雌性小鼠心肌 IR 后心功能障碍。
  • microRNA-210 模拟物静脉注射可逆转 IR 损伤与心功能障碍。
  • microRNA-210 通过靶向甘油-3-磷酸脱氢酶调控线粒体 ROS 与生物能量学。

核心结论

  • microRNA-210 靶向甘油-3-磷酸脱氢酶调控线粒体生物能量学与 ROS 通量,改善小鼠心肌 IR 损伤后的心脏功能。

研究设计与样本

  • 在小鼠心肌缺血再灌注(IR)模型中比较 microRNA-210 缺失与野生型的损失功能与获得功能实验。
  • 采用超声心动图评估心脏功能,Seahorse XF24 分析仪检测心肌线粒体生物能量学。

主要发现

  • microRNA-210 缺失显著加重雄性小鼠心肌 IR 后长达 6 周的心脏功能障碍,雌性小鼠未见此效应。
  • 静脉注射 microRNA-210 模拟物阻断该效应,并恢复加重的 IR 损伤与心脏功能障碍。
  • microRNA-210 抑制线粒体氧耗、增加糖酵解活性并降低 IR 期间心脏线粒体 ROS 通量。
  • 线粒体 ROS 抑制剂 MitoQ 可逆转 microRNA-210 缺失的效应。
  • 敲低甘油-3-磷酸脱氢酶可消除 microRNA-210 缺失诱导的线粒体 ROS 产生与心肌梗死增加,并改善 IR 后左心室缩短分数与射血分数。

关键数值与推荐

  • microRNA-210 缺失加重雄性小鼠心肌 IR 后长达 6 周的心脏功能障碍。
  • MitoQ 抑制线粒体 ROS 可逆转 microRNA-210 缺失的效应。
  • 敲低甘油-3-磷酸脱氢酶改善 IR 后左心室缩短分数与射血分数。

临床怎么用

  • 提示 microRNA-210 及其靶点甘油-3-磷酸脱氢酶可能作为缺血性心脏病治疗的新机制与靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Ischemic heart disease remains a leading cause of death worldwide. In this study, we test the hypothesis that microRNA-210 protects the heart from myocardial ischemia-reperfusion (IR) injury by controlling mitochondrial bioenergetics and reactive oxygen species (ROS) flux. METHODS: Myocardial infarction in an acute setting of IR was examined through comparing loss- versus gain-of-function experiments in microRNA-210-deficient and wild-type mice. Cardiac function was evaluated by echocardiography. Myocardial mitochondria bioenergetics was examined using a Seahorse XF24 Analyzer. RESULTS: MicroRNA-210 deficiency significantly exaggerated cardiac dysfunction up to 6 weeks after myocardial IR in male, but not female, mice. Intravenous injection of microRNA-210 mimic blocked the effect and recovered the increased myocardial IR injury and cardiac dysfunction. Analysis of mitochondrial metabolism revealed that microRNA-210 inhibited mitochondrial oxygen consumption, increased glycolytic activity, and reduced mitochondrial ROS flux in the heart during IR injury. Inhibition of mitochondrial ROS with MitoQ consistently reversed the effect of microRNA-210 deficiency. Mechanistically, we showed that mitochondrial glycerol-3-phosphate dehydrogenase is a novel target of microRNA-210 in the heart, and loss-of-function and gain-of-function experiments revealed that glycerol-3-phosphate dehydrogenase played a key role in the microRNA-210-mediated effect on mitochondrial metabolism and ROS flux in the setting of heart IR injury. Knockdown of glycerol-3-phosphate dehydrogenase negated microRNA-210 deficiency-induced increases in mitochondrial ROS production and myocardial infarction and improved left ventricular fractional shortening and ejection fraction after the IR treatment. CONCLUSIONS: MicroRNA-210 targeting glycerol-3-phosphate dehydrogenase controls mitochondrial bioenergetics and ROS flux and improves cardiac function in a murine model of myocardial infarction in the setting of IR injury. The findings suggest new insights into the mechanisms and therapeutic targets for treatment of ischemic heart disease.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Song, Dasgupta, Mulder, et al. MicroRNA-210 Controls Mitochondrial Metabolism and Protects Heart Function in Myocardial Infarction. Circulation. 2022. PMID: 35296158. doi:10.1161/CIRCULATIONAHA.121.056929

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。